Published in Infect Immun on September 01, 1997
Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc Natl Acad Sci U S A (2000) 7.39
Inducible nitric oxide synthase: what difference does it make? J Clin Invest (1997) 3.72
Innate immunity to Mycobacterium tuberculosis. Clin Microbiol Rev (2002) 2.79
Identification of substrates of the Mycobacterium tuberculosis proteasome. EMBO J (2006) 1.96
1,25-Dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line. Infect Immun (1998) 1.96
The inducible nitric oxide synthase locus confers protection against aerogenic challenge of both clinical and laboratory strains of Mycobacterium tuberculosis in mice. Infect Immun (2001) 1.73
Response to reactive nitrogen intermediates in Mycobacterium tuberculosis: induction of the 16-kilodalton alpha-crystallin homolog by exposure to nitric oxide donors. Infect Immun (1999) 1.65
Nitric oxide production and nitric oxide synthase type 2 expression by human mononuclear phagocytes: a review. Mol Med (1998) 1.62
Host innate immune response to Mycobacterium tuberculosis. J Clin Immunol (2007) 1.61
Down-modulation of lung immune responses by interleukin-10 and transforming growth factor beta (TGF-beta) and analysis of TGF-beta receptors I and II in active tuberculosis. Infect Immun (2004) 1.60
A novel antioxidant gene from Mycobacterium tuberculosis. J Exp Med (1997) 1.52
Induction of inducible nitric oxide synthase-NO* by lipoarabinomannan of Mycobacterium tuberculosis is mediated by MEK1-ERK, MKK7-JNK, and NF-kappaB signaling pathways. Infect Immun (2001) 1.42
Mycobacteria inhibit nitric oxide synthase recruitment to phagosomes during macrophage infection. Infect Immun (2004) 1.31
Silencing of oxidative stress response in Mycobacterium tuberculosis: expression patterns of ahpC in virulent and avirulent strains and effect of ahpC inactivation. Infect Immun (2001) 1.29
Mycobacteriocidal action of exogenous nitric oxide. Antimicrob Agents Chemother (1999) 1.21
Effect of oestrogen on Mycobacterium avium complex pulmonary infection in mice. Clin Exp Immunol (2001) 1.18
Nitric oxide-mediated regulation of gamma interferon-induced bacteriostasis: inhibition and degradation of human indoleamine 2,3-dioxygenase. Infect Immun (2004) 1.16
Mycobacterium tuberculosis expresses methionine sulphoxide reductases A and B that protect from killing by nitrite and hypochlorite. Mol Microbiol (2009) 1.15
Role of glutathione in macrophage control of mycobacteria. Infect Immun (2003) 1.14
noxR3, a novel gene from Mycobacterium tuberculosis, protects Salmonella typhimurium from nitrosative and oxidative stress. Infect Immun (1999) 1.11
Nitric oxide inhibits Coxiella burnetii replication and parasitophorous vacuole maturation. Infect Immun (2002) 1.05
Interferon-alphabeta mediates partial control of early pulmonary Mycobacterium bovis bacillus Calmette-Guérin infection. Immunology (2006) 1.01
Role of the NF-kappaB signaling pathway and kappaB cis-regulatory elements on the IRF-1 and iNOS promoter regions in mycobacterial lipoarabinomannan induction of nitric oxide. Infect Immun (2003) 1.00
The role of nitric oxide in mycobacterial infections. Immune Netw (2009) 0.97
Induction of nitric oxide release from the human alveolar epithelial cell line A549: an in vitro correlate of innate immune response to Mycobacterium tuberculosis. Immunology (2004) 0.97
Epigenetic silencing of the human NOS2 gene: rethinking the role of nitric oxide in human macrophage inflammatory responses. J Immunol (2014) 0.96
Bacille Calmette-Guérin (BCG)-associated inflammation and fibrosis: modulation by recombinant BCG expressing interferon-gamma (IFN-gamma). Clin Exp Immunol (2000) 0.95
Aerosolized gamma interferon (IFN-gamma) induces expression of the genes encoding the IFN-gamma-inducible 10-kilodalton protein but not inducible nitric oxide synthase in the lung during tuberculosis. Infect Immun (2004) 0.93
microRNA-146a promotes mycobacterial survival in macrophages through suppressing nitric oxide production. Sci Rep (2016) 0.92
Nitric Oxide Synthesis is Modulated by 1,25-Dihydroxyvitamin D3 and Interferon-gamma in Human Macrophages after Mycobacterial Infection. Immune Netw (2009) 0.90
The gills are an important site of iNOS expression in rainbow trout Oncorhynchus mykiss after challenge with the gram-positive pathogen Renibacterium salmoninarum. Immunology (2000) 0.90
Interactions between naïve and infected macrophages reduce Mycobacterium tuberculosis viability. PLoS One (2011) 0.87
Human monocytic U937 cells kill Salmonella in vitro by NO-independent mechanisms. Infect Immun (1999) 0.87
Dipterinyl calcium pentahydrate inhibits intracellular mycobacterial growth in human monocytes via the C-C chemokine MIP-1β and nitric oxide. Infect Immun (2013) 0.84
Impaired pulmonary nitric oxide bioavailability in pulmonary tuberculosis: association with disease severity and delayed mycobacterial clearance with treatment. J Infect Dis (2013) 0.83
Trans-species communication in the Mycobacterium tuberculosis-infected macrophage. Immunol Rev (2015) 0.80
Role for NOD2 in Mycobacterium tuberculosis-induced iNOS expression and NO production in human macrophages. J Leukoc Biol (2015) 0.79
Differential trafficking of TLR1 I602S underlies host protection against pathogenic mycobacteria. J Immunol (2012) 0.79
Nitrotyrosine formation after activation of murine macrophages with mycobacteria and mycobacterial lipoarabinomannan. Clin Exp Immunol (1999) 0.78
Efficacy of Leishmania donovani trypanothione reductase, identified as a potent Th1 stimulatory protein, for its immunogenicity and prophylactic potential against experimental visceral leishmaniasis. Parasitol Res (2013) 0.78
A role for interleukin-17A in modulating intracellular survival of Mycobacterium bovis bacillus Calmette-Guérin in murine macrophages. Immunology (2013) 0.77
Naturally produced opsonizing antibodies restrict the survival of Mycobacterium tuberculosis in human macrophages by augmenting phagosome maturation. Open Biol (2015) 0.77
Novel high throughput pooled shRNA screening identifies NQO1 as a potential drug target for host directed therapy for tuberculosis. Sci Rep (2016) 0.75
Immunoprotective responses of T helper type 1 stimulatory protein-S-adenosyl-L-homocysteine hydrolase against experimental visceral leishmaniasis. Clin Exp Immunol (2016) 0.75
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem (1982) 27.26
Tuberculosis: commentary on a reemergent killer. Science (1992) 14.51
Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol (1988) 14.21
Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med (1992) 10.08
Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol (1990) 8.85
Biochemistry of nitric oxide and its redox-activated forms. Science (1992) 7.72
Interferon-gamma and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages. Eur J Immunol (1988) 4.04
Impact of HIV on tuberculosis in Zambia: a cross sectional study. BMJ (1990) 3.84
Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes. J Infect Dis (1993) 3.75
Mechanisms involved in mycobacterial growth inhibition by gamma interferon-activated bone marrow macrophages: role of reactive nitrogen intermediates. Infect Immun (1991) 3.54
Activation of tuberculostatic macrophage functions by gamma interferon, interleukin-4, and tumor necrosis factor. Infect Immun (1990) 3.35
IL-10 synergizes with IL-4 and transforming growth factor-beta to inhibit macrophage cytotoxic activity. J Immunol (1992) 2.78
Bactericidal activity of peroxynitrite. Arch Biochem Biophys (1992) 2.61
Multiple forms of IFN-beta 2/IL-6 in serum and body fluids during acute bacterial infection. J Immunol (1989) 2.19
The immunology of mycobacterial diseases. Am Rev Respir Dis (1986) 1.96
Human alveolar and peritoneal macrophages mediate fungistasis independently of L-arginine oxidation to nitrite or nitrate. Am Rev Respir Dis (1990) 1.90
Human monocytes/macrophages: NO or no NO? J Leukoc Biol (1994) 1.83
Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia. Am J Respir Crit Care Med (1994) 1.75
Tyrosine modification by reactive nitrogen species: a closer look. Arch Biochem Biophys (1995) 1.45
Parallel induction of tetrahydrobiopterin biosynthesis and indoleamine 2,3-dioxygenase activity in human cells and cell lines by interferon-gamma. Biochem J (1989) 1.31
Inhibitory activity of unstimulated alveolar macrophages on T-lymphocyte blastogenic response. Am Rev Respir Dis (1978) 1.27
Induction of early-response genes KC and JE by mycobacterial lipoarabinomannans: regulation of KC expression in murine macrophages by Lsh/Ity/Bcg (candidate Nramp). Infect Immun (1994) 1.25
Biosynthesis and metabolism of pterins in peripheral blood mononuclear cells and leukemia lines of man and mouse. Eur J Biochem (1987) 1.15
Guinea pig alveolar macrophages probably kill M. tuberculosis H37Rv and H37Ra in vivo by producing hydrogen peroxide. Adv Exp Med Biol (1983) 0.96
Abundant production of nitric oxide from murine macrophages by direct stimulation of tumor cells. Biochem Biophys Res Commun (1993) 0.86
Bacteriostatic activity of BCG/PPD-activated macrophages against Mycobacterium fortuitum does not involve reactive nitrogen or oxygen intermediates. Scand J Immunol (1994) 0.84
Human alveolar macrophages of anergic patients with lung cancer lack the responsiveness to recombinant interferon gamma. Chest (1991) 0.82
Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. Nature (2002) 28.79
Functional annotation of a full-length mouse cDNA collection. Nature (2001) 23.61
PCR detection of metallo-beta-lactamase gene (blaIMP) in gram-negative rods resistant to broad-spectrum beta-lactams. J Clin Microbiol (1996) 6.68
Multifocal outbreaks of metallo-beta-lactamase-producing Pseudomonas aeruginosa resistant to broad-spectrum beta-lactams, including carbapenems. Antimicrob Agents Chemother (1996) 5.36
Genomic DNA fingerprinting by pulsed-field gel electrophoresis as an epidemiological marker for study of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. J Clin Microbiol (1991) 4.33
Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain (2007) 3.64
Polymorphisms of UDP-glucuronosyltransferase gene and irinotecan toxicity: a pharmacogenetic analysis. Cancer Res (2000) 3.32
Plasmid-mediated AmpC-type beta-lactamase isolated from Klebsiella pneumoniae confers resistance to broad-spectrum beta-lactams, including moxalactam. Antimicrob Agents Chemother (1993) 3.19
Virulence for mice of Klebsiella strains belonging to the O1 group: relationship to their capsular (K) types. Infect Immun (1983) 2.93
Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica. Neurology (2005) 2.77
Spread of drug-resistant Streptococcus pneumoniae in Asian countries: Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study. Clin Infect Dis (1999) 2.74
Unmasking of latent hypoparathyroidism in a child with partial DiGeorge syndrome by ethylenediaminetetraacetic acid infusion. Eur J Pediatr (1993) 2.69
Interactions of outer membrane proteins O-8 and O-9 with peptidoglycan sacculus of Escherichia coli K-12. J Biochem (1976) 2.61
Mullerian inhibiting substance in humans: normal levels from infancy to adulthood. J Clin Endocrinol Metab (1996) 2.37
Depth of invasion as a predictive factor for cervical lymph node metastasis in tongue carcinoma. Head Neck (1997) 2.21
Inactivating mutations in the 25-hydroxyvitamin D3 1alpha-hydroxylase gene in patients with pseudovitamin D-deficiency rickets. N Engl J Med (1998) 2.11
Prognostic value of performance status assessed by patients themselves, nurses, and oncologists in advanced non-small cell lung cancer. Br J Cancer (2001) 2.01
Campylobacter fetus subspecies fetus cellulitis associated with bacteremia in debilitated hosts. Clin Infect Dis (1998) 2.01
EEC syndrome (ectrodactyly, ectodermal dysplasia and cleft lip/palate) with a balanced reciprocal translocation between 7q11.21 and 9p12 (or 7p11.2 and 9q12) in three generations. Clin Genet (1991) 1.96
Transgenic mouse model for skin malignant melanoma. Oncogene (1998) 1.90
Changes in distribution of hepatic blood flow induced by intra-arterial infusion of angiotensin II in human hepatic cancer. Cancer (1985) 1.84
Nosocomial spread of cephem-resistant Escherichia coli strains carrying multiple Toho-1-like beta-lactamase genes. Antimicrob Agents Chemother (1997) 1.84
Evaluation of Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test and Roche PCR-microwell plate hybridization method (AMPLICOR MYCOBACTERIUM) for direct detection of mycobacteria. J Clin Microbiol (1996) 1.82
AQP4 antibody-positive Thai cases: clinical features and diagnostic problems. Neurology (2011) 1.77
Measurements of serum müllerian inhibiting substance in the evaluation of children with nonpalpable gonads. N Engl J Med (1997) 1.74
GATA3 abnormalities and the phenotypic spectrum of HDR syndrome. J Med Genet (2001) 1.71
Alcohol-related cancers and aldehyde dehydrogenase-2 in Japanese alcoholics. Carcinogenesis (1998) 1.70
Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase. Oncogene (2010) 1.68
Effect of acetazolamide reactivity on [corrected] long-term outcome in patients with major cerebral artery occlusive diseases. Stroke (1998) 1.64
Phakomatosis pigmentovascularis type IVa. Arch Dermatol (1985) 1.63
Prognostic significance of p53 mutations and 3p deletions in primary resected non-small cell lung cancer. Cancer Res (1993) 1.61
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Compressibility-structure relationship of globular proteins. Biochemistry (1986) 1.58
Levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea--hypopnea syndrome. Blood (2001) 1.58
Expression of factor X and its significance for the determination of paramyxovirus tropism in the chick embryo. EMBO J (1992) 1.54
Establishment and characterization of a new human mesothelioma cell line (T-85) from malignant peritoneal mesothelioma with remarkable thrombocytosis. Pathol Int (1995) 1.50
Detection of abnormal cardiac adrenergic neuron activity in adriamycin-induced cardiomyopathy with iodine-125-metaiodobenzylguanidine. J Nucl Med (1992) 1.48
Gene expression of erythropoietin in renal cell carcinoma. Intern Med (1999) 1.47
Lymphomatous features of aggressive NK cell leukaemia/lymphoma with massive necrosis, haemophagocytosis and EB virus infection. Histopathology (2000) 1.47
Alterations in the antibody response to bovine serum albumin by capsular polysaccharide of Klebsiella pneumoniae. J Immunol (1971) 1.46
Clinical significance of elevated soluble interleukin-6 receptor levels in the sera of patients with plasma cell dyscrasias. Br J Haematol (1995) 1.43
Interleukin-10 level in sputum is reduced in bronchial asthma, COPD and in smokers. Eur Respir J (1999) 1.42
Adenosine deaminase isozymes in tuberculous pleural effusion. J Lab Clin Med (1996) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Intractable hiccup and nausea in neuromyelitis optica with anti-aquaporin-4 antibody: a herald of acute exacerbations. J Neurol Neurosurg Psychiatry (2008) 1.41
Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers. Cancer Res (1996) 1.41
Prognostic value of pleural effusion in patients with non-small cell lung cancer. Clin Cancer Res (1997) 1.39
Hypergonadotropic hypogonadism in a 3-year-old girl with blepharophimosis, ptosis, and epicanthus inversus syndrome. Horm Res (1998) 1.39
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Effect of capsular polysaccharide of Klebsiella pneumoniae on the differentiation and functional capacity of macrophages cultured in vitro. Microbiol Immunol (1977) 1.38
Effectiveness of epidural anesthesia for external cephalic version (ECV). J Perinatol (2010) 1.38
Identifying pathogenic genetic background of simplex or multiplex retinitis pigmentosa patients: a large scale mutation screening study. J Med Genet (2008) 1.38
Identification of the second gonadotropin-releasing hormone in chicken hypothalamus: evidence that gonadotropin secretion is probably controlled by two distinct gonadotropin-releasing hormones in avian species. Proc Natl Acad Sci U S A (1984) 1.38
Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica. Mult Scler (2007) 1.37
Mortality and mobility after hip fracture in Japan: a ten-year follow-up. J Bone Joint Surg Br (2007) 1.36
Functional outcome after hip fracture in Japan. Clin Orthop Relat Res (1998) 1.36
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Isolation of porcine follicular fluid inhibin of 32K daltons. Biochem Biophys Res Commun (1985) 1.34
Identification and characterization of a novel follistatin-like protein as a binding protein for the TGF-beta family. J Biol Chem (2000) 1.33
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Binding of pEL98 protein, an S100-related calcium-binding protein, to nonmuscle tropomyosin. J Cell Biol (1994) 1.32
Surface components of Porphyromonas gingivalis. J Periodontal Res (2008) 1.29
Occurrence of acute large and edematous callosal lesions in neuromyelitis optica. Mult Scler (2009) 1.28
Aberrant melanogenesis and melanocytic tumour development in transgenic mice that carry a metallothionein/ret fusion gene. EMBO J (1991) 1.28
Interleukin-8 activity correlates with histological severity in Helicobacter pylori-associated antral gastritis. Am J Gastroenterol (1996) 1.28
HDR syndrome (hypoparathyroidism, sensorineural deafness, renal dysplasia) associated with del(10)(p13). Am J Med Genet (1997) 1.28
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Phase II trial of gefitinib alone without radiation therapy for Japanese patients with brain metastases from EGFR-mutant lung adenocarcinoma. Lung Cancer (2013) 1.27
Studies on the pathogenicity of human-origin parainfluenza virus in the brain of mice. Microbiol Immunol (1978) 1.26
Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients. Neurology (2012) 1.25
Further Studies of the polysaccharide of Klebsiella pneumoniae possessing strong adjuvanticity. I. Production of the adjuvant polysaccharide by noncapsulated mutant. Microbiol Immunol (1981) 1.25
The spread of a pathogenic and an apathogenic strain of Newcastle disease virus in the chick embryo as depending on the protease sensitivity of the virus glycoproteins. J Gen Virol (1979) 1.24
Non-specific stimulation of immunoglobulin synthesis in mice by capsular polysaccharide of Klebsiella pneumoniae. Immunology (1974) 1.23
4-hydroxynonenal induces a cellular redox status-related activation of the caspase cascade for apoptotic cell death. J Cell Sci (2000) 1.23
Mycobacterium growth indicator tube testing in conjunction with the AccuProbe or the AMPLICOR-PCR assay for detecting and identifying mycobacteria from sputum samples. J Clin Microbiol (1997) 1.22
Diagnostic controversy: the diagnosis of childhood growth hormone deficiency revisited. J Clin Endocrinol Metab (1995) 1.21
Randomized scheduling feasibility study of S-1 for adjuvant chemotherapy in advanced head and neck cancer. Br J Cancer (2005) 1.21
A computer simulation study of normal and abnormal hip joint contact pressure. Arch Orthop Trauma Surg (1995) 1.20
Clinical factors associated with fluconazole resistance and short-term survival in patients with Candida bloodstream infection. Eur J Clin Microbiol Infect Dis (2004) 1.20
Down-regulation of the surface expression of class I MHC antigens by human cytomegalovirus. Virology (1993) 1.20
Relationship between steroid dosage and osteonecrosis of the femoral head after renal transplantation as measured by magnetic resonance imaging. Transplant Proc (1998) 1.20
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
Experimental test of quantum contextuality in neutron interferometry. Phys Rev Lett (2009) 1.19
Immunosuppressive activity induced by nitric oxide in culture supernatant of activated rat alveolar macrophages. Immunology (1992) 1.19
Genetic alteration of the beta-catenin gene (CTNNB1) in human lung cancer and malignant mesothelioma and identification of a new 3p21.3 homozygous deletion. Oncogene (2001) 1.18
Activin A: an autocrine inhibitor of initiation of DNA synthesis in rat hepatocytes. J Clin Invest (1993) 1.18
Close cooperation between infectious disease physicians and attending physicians can result in better management and outcome for patients with Staphylococcus aureus bacteraemia. Clin Microbiol Infect (2010) 1.17
RET finger protein is a transcriptional repressor and interacts with enhancer of polycomb that has dual transcriptional functions. J Biol Chem (2000) 1.17